Propofol is an extremely effective anesthetic which is manufactured as an emulsion and is delivered intravenously. AsraZeneca made the first useful version in 1986 (Diprivan), Sandoz now makes another.
In an age of accountability, where every dollar counts, Deborah Dick-Rath talks to industry insiders about how they can make a measurable difference in their marketing mix
Predicting Product Launch Success: An Ace in the Whole
Can pharma companies really predict the success of new product launches? Patrick Howie and Mike Luby report on how pharmas can hone in on physicians’ actual prescribing behavior versus stated intentions
Certified and accredited CME has undergone a sea-change in recent years, with policies now in place emphasizing quality and leaving little room for bias (not that you’d know it, for all the buzz about conflicts of interest)
Buyer beware: behavioral science vs. behavioral marketing
In the digital world, new buzz words sprout and spread faster than the crabgrass in my lawn. One of those recent buzz words is behavioral marketing (sometimes called behavioral targeting).
Eli Lilly’s new head of public relations, Bart Peterson, says most Americans agree that healthcare reform is way past due, and believes at least the early stages of reform will be achieved this year.
2009 Med Ed Review
July 15, 2009
5:17 pm
With increased regulatory scrutiny and a slow-down in new product approvals already constricting budgets, the last thing the medical education sector needed was a deep recession. MM&M checks the pulse of independent CME providers and promotional med ed firms
Will digital budgets ever match TV?
July 15, 2009
4:00 am
Will media budgets trend toward digital and away from televised DTC this year, as several pharmaceutical executives have intoned? Or will digital media continue to be nickel and dimed?
Roche added a new component to its $14 million diabetes education campaign, which pairs healthcare practitioners with Roche staff to improve dialogue between diabetic patients and their caregivers.
The House of Representatives’ version of the healthcare reform bill, dubbed the America’s Affordable Health Choices Act of 2009, includes the provisions of the Physician Payment Sunshine Act, which would mandate sweeping transparency measures for pharmas.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix